We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




First and Only AI Technology Identifies Suspected Strokes from Brain Scans

By MedImaging International staff writers
Posted on 02 Aug 2023
Print article
Image: The Full Brain Solution identifies MeVOs and LVOs in addition to aneurysms and hemorrhages (Photo courtesy of Aidoc)
Image: The Full Brain Solution identifies MeVOs and LVOs in addition to aneurysms and hemorrhages (Photo courtesy of Aidoc)

There is a significant prevalence of posterior large vessel occlusions (LVOs) and medium vessel occlusions (MeVOs). Each year in the United States, there are approximately 795,000 cases of strokes, with 87% being ischemic strokes. It is estimated that 25-40% of ischemic strokes are MeVOs and 24-46% of all ischemic strokes are LVOs, with 20-25% of LVOs being posterior. Now, an innovative solution significantly expands the anatomy assessed by artificial intelligence (AI) for potential strokes on computed tomography (CT) scans, facilitating the identification and care coordination of patients with MeVOs and both posterior and anterior LVOs.

Aidoc (Tel Aviv-Yafo, Israel) has rolled out its pioneering Full Brain Solution, marking a significant leap in medical technology in patient care. The Full Brain Solution is the first and sole AI technology capable of identifying suspected posterior and anterior LVOs and MeVOs on CT scans. The inclusion of posterior LVO and MeVO allows roughly double the number of patients to quickly receive life-saving therapy with AI-powered care coordination. In addition to acute ischemic stroke, the Full Brain Solution utilizes diverse AI technologies, including image-based identification and natural language processing, to identify and manage care for patients suffering from intracerebral hemorrhage, subdural hemorrhage, and brain aneurysms. This makes it the most comprehensive neurovascular AI solution.

The Full Brain Solution is deployed through Aidoc's proprietary operating system, aiOS, which allows organizations to consistently roll out AI solutions in large volumes and overcome hurdles related to legacy IT systems and separate physician workflows. The aiOS smoothly integrates with current IT infrastructure, facilitating the necessary scale to realize the full potential of AI in healthcare. It is also the only platform integrated into electronic health records (EHR). AI has proven highly successful in improving workflow for patients with anterior LVOs, reducing the time to treatment by nearly half. With Aidoc's Full Brain Solution, these advancements can extend to a substantially larger patient population, leading to improved care and ultimately, better patient outcomes.

"AI continues to drive significant gains and contributions in addressing the challenges health systems are facing," said Elad Walach, CEO, Aidoc. "Our groundbreaking Full Brain Solution is propelling AI into new and needed territories and proving impact to facilities by cutting the time to treatment nearly in half for twice as many patients. Our vision is to continue pushing boundaries, transforming the lives of a significantly larger patient population, elevating the standard of care, and driving remarkable improvements in patient outcomes."

Related Links:
Aidoc 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound Table
Ergonomic Advantage (EA) Line
New
Ultrasound Table
Powered Ultrasound Table-Flat Top
New
Wireless Handheld Ultrasound System
TE Air

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.